Last reviewed · How we verify
NCT05523830: EEPAC
Estimation of Energy Expenditure and Physical Activity Classification With Wearables
trial testing No Intervention in Energy Metabolism in 56 participants. Completed in 29 June 2023.
29 June 2023
Quick facts
| Lead sponsor | Maastricht University Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 18 May 2022 |
| Primary completion | 29 June 2023 |
| Estimated completion | 29 June 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- No Intervention
Conditions studied
- Energy Metabolism — all drugs for Energy Metabolism →
- Algorithms — all drugs for Algorithms →
Sponsor
Maastricht University Medical Center
Who can join
Adults 18 to 64, any sex, with Energy Metabolism or Algorithms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Regular physical activity (PA) is proven to help prevent and treat several non-communicable diseases such as heart disease, stroke, and diabetes. Intensity is a key characteristic of PA that can be assessed by estimating energy expenditure (EE). However, the accuracy of the estimation of EE based on accelerometers are lacking. It has been suggested that the addition of physiological signals can improve the estimation. How much each signal can add to the explained variation and how they can improve the estimation is still unclear. The goal of the current study is twofold: to explore the contribution of heart rate (HR), breathing rate (BR) and skin temperature to the estimation of EE develop and validate a statistical model to estimate EE in simulated free-living conditions based on the relevant physiological signals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05523830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Intervention
Trials testing the same drug.
- NCT07353099 — A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma · not yet recruiting
- NCT07429942 — A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Recei · not yet recruiting
- NCT07521917 — Child Abuse and Neglect Awareness Training in Nursing Students · NA · not yet recruiting
- NCT07319832 — A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome · recruiting
- NCT07425574 — A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · recruiting
Other recruiting trials for Energy Metabolism
Currently open trials in the same condition.
- NCT07454252 — Retrospective Monocentric Evaluation of Biomarkers Associated With Bone, Muscle and Energy Metabolism · recruiting
- NCT07056504 — Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation · recruiting
- NCT07478211 — Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery · recruiting
- NCT05736302 — Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water · recruiting
- NCT06483542 — Bionenergetic Balance During CVVH · active not recruiting
Other Maastricht University Medical Center trials
Trials by the same sponsor.
- NCT04603261 — Time to Excretion of Contrast, a Maastricht Prospective Observational Study · withdrawn
- NCT04598516 — Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 · withdrawn
- NCT04597892 — Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast · withdrawn
- NCT07287358 — Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II · NA · not yet recruiting
- NCT07501780 — Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05523830 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maastricht University Medical Center
- Last refreshed: 3 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05523830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing